{"prompt": "['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', '5.1.2 There have been very rare reports of acupuncture causing minor nerve damage,', 'hematomas (bleeding under the skin or inside your body), infections, or', 'pneumothorax (puncture of a lung).', '5.2', 'Adverse Event List for Nerve Conduction Studies', '5.2.1 Standard risks include discomfort or pain from the procedure.', '5.3', 'Adverse Event List for Biopsies', '5.3.1 Risks associated with skin biopsies may include brief pain (common), bleeding or', 'bruising (uncommon), or in rare instances, infection (rare). Standard precautions', 'will be used for these tests. The risks are not expected to be different from', 'routine clinical procedures. We do not expect any long-term, or life-threatening', 'risks.', '5.4', 'Adverse Event List for Ultrasound', '5.4.1 Ultrasound is a safe procedure. Patients may experience a slight warming and', 'coldness from the gel.', '5.5', 'Adverse Event Characteristics', 'CTCAE term (AE description) and grade: The descriptions and grading scales found in', 'the revised NCI Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 will', 'be utilized for AE reporting. All appropriate treatment areas should have access to a copy of', 'the CTCAE version 4.0. A copy of the CTCAE version 4.0 can be downloaded from the', 'CTEP web site (http://ctep.cancer.gov).', '\\'Expectedness\\': AEs can be \"Unexpected\\' or \"Expected\\' (see Section 7.1 above) for', 'expedited reporting purposes only.', 'Attribution of the AE:', 'Definite - The AE is clearly related to the study treatment.', 'Probable - The AE is likely related to the study treatment.', 'Possible - The AE may be related to the study treatment.', 'Unlikely - The AE is doubtfully related to the study treatment.', 'Unrelated - The AE is clearly NOT related to the study treatment.', '5.6', 'STRC SAE Reporting Requirements', 'The Safety and Toxicity Reporting Committee (STRC) is responsible for reviewing SAEs for WFBCCC', 'Institutional studies as outlined in.', 'The Safety and Toxicity Reporting Committee (STRC) is responsible for reviewing SAEs for', 'WFBCCC Institutional studies as outlined in Appendix K. All Adverse Events that occur', 'during protocol intervention and are coded as either 1) unexpected grade 4, 2)', 'unplanned inpatient hospitalization > 24 hours (regardless of grade), or grade 5 (death)', 'Page 14 of 55']['Acupuncture for Chemotherapy-Induced Peripheral Neuropathy Among Cancer Patients', 'Wake Forest Baptist Comprehensive Cancer Center (WFBCCC)', 'CCCWFU # 97118', 'must be reported to the STRC using the using the SAE console in WISER. All WFBCCC', 'Clinical Protocol and Data Management (CPDM) staff members assisting a Principal', 'Investigator in investigating, documenting and reporting an SAE qualifying for STRC reporting', 'are responsible for informing a clinical member of the STRC as well as the entire committee', 'via the email notification procedure of the occurrence of an SAE.', '5.7', 'WFUHS IRB AE Reporting Requirements', 'Any unanticipated problems involving risks to subjects or others and adverse events shall be promptly', 'reported to the IRB, according to institutional policy. Reporting to the IRB is required regardless of the', 'funding source, study sponsor, or whether the event involves an investigational or marketed drug,', 'biologic or device. Reportable events are not limited to physical injury, but include psychological,', 'economic and social harm. Reportable events may arise as a result of drugs, biological agents,', 'devices, procedures or other interventions, or as a result of questionnaires, surveys, observations or', 'other interactions with research subjects.', 'All members of the research team are responsible for the appropriate reporting to the IRB and other', 'applicable parties of unanticipated problems involving risk to subjects or others. The Principal', 'Investigator, however, is ultimately responsible for ensuring the prompt reporting of unanticipated', 'problems involving risk to subjects or others to the IRB. The Principal Investigator is also responsible', 'for ensuring that all reported unanticipated risks to subjects and others which they receive are reviewed', 'to determine whether the report represents a change in the risks and/or benefits to study participants,', 'and whether any changes in the informed consent, protocol or other study-related documents are', 'required.', 'Any unanticipated problems involving risks to subjects or others occurring at a site where the study has', 'been approved by the WFUHS IRB (internal events) must be reported to the WFUHS IRB within 7', 'calendar days of the investigator or other members of the study team becoming aware of the event.', 'Any unanticipated problems involving risks to subjects or others occurring at another site conducting', 'the same study that has been approved by the WFUHS IRB (external events) must be reported to the', 'WFUHS IRB within 7 calendar days of the investigator or other members of the study team becoming', 'aware of the event.', 'Any event, incident, experience, or outcome that alters the risk versus potential benefit of the research', 'and as a result warrants a substantive change in the research protocol or informed consent', 'process/document in order to insure the safety, rights or welfare of research subjects.', '6.0', 'Duration of Follow-up', 'Following recruitment, patients will be scheduled for neurodiagnostic assessments with 2', 'weeks. Acupuncture treatments will occur over 10 weeks, after which, patients will return to', 'neurology for follow-up assessment within 2 weeks. Patients randomized to usual care will have', 'the opportunity to receive four acupuncture treatments All patient will receive a telephone foll-', 'up call 30 days (+ or - 5 days) after their follow-up neurodiagnosito assessments to identify', 'whether any adverse events have occurred.', 'Page 15 of 55']\n\n###\n\n", "completion": "END"}